Abeona Therapeutics Inc’s filing revealed that its Director Charles Faith L. acquired Company’s shares for reported $24764.0 on Apr 26 ’24. In the deal valued at $3.28 per share,7,550 shares were bought. As a result of this transaction, Charles Faith L. now holds 78,323 shares worth roughly $0.27 million.
Then, Seshadri Vishwas bought 10,000 shares, generating $32,000 in total proceeds. Upon buying the shares at $3.20, the Chief Executive Officer now owns 538,260 shares.
Before that, O’Malley Brendan M. bought 8,600 shares. Abeona Therapeutics Inc shares valued at $27,864 were divested by the SVP, General Counsel at a price of $3.24 per share. As a result of the transaction, O’Malley Brendan M. now holds 188,718 shares, worth roughly $0.65 million.
Cantor Fitzgerald upgraded its Abeona Therapeutics Inc [ABEO] rating to an Overweight from a a Neutral in a research note published recently. A number of analysts have revised their coverage, including B. Riley FBR’s analysts, who began to cover the stock in mid September with a ‘”a Buy”‘ rating. SVB Leerink began covering ABEO with “an Outperform” recommendation on February 10, 2020.
Price Performance Review of ABEO
On Monday, Abeona Therapeutics Inc [NASDAQ:ABEO] saw its stock jump 5.52% to $3.44. Over the last five days, the stock has lost -53.26%. Abeona Therapeutics Inc shares have fallen nearly -31.34% since the year began. Nevertheless, the stocks have risen 9.90% over the past one year. While a 52-week high of $9.01 was reached on 03/06/24, a 52-week low of $2.83 was recorded on 04/25/24. SMA at 50 days reached $7.15, while 200 days put it at $5.04. A total of 2.09 million shares were traded, compared to the trading of 2.22 million shares in the previous session.
Levels Of Support And Resistance For ABEO Stock
The 24-hour chart illustrates a support level at 3.28, which if violated will result in even more drops to 3.12. On the upside, there is a resistance level at 3.69. A further resistance level may holdings at 3.94. The Relative Strength Index (RSI) on the 14-day chart is 23.50, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -2.77, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.78%. Stochastics %K at 4.57% indicates the stock is a buying.
